Bivision Biomedical Technology (Nanjing) Co., Ltd.
PrivateLast Round
Series B
May 19, 2026
Total Funding Raised
$99.7M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bivision Biomedical Technology (Nanjing) Co., Ltd. is a biopharmaceutical company that develops radiopharmaceutical therapies for the treatment and diagnosis of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bivision Biomedical Technology (Nanjing) Co., Ltd. Comparables
Compare Bivision Biomedical Technology (Nanjing) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| C-Ray Therapeutics | 86% | |
| Suzhou SmartNuclide Biopharmaceutical Co., Ltd. | 86% | |
| ARTBIO | 85% |
Bivision Biomedical Technology (Nanjing) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 19, 2026 | ||||
| Series A Extension | Jan 17, 2025 | ||||
| Series A | Jul 26, 2024 | ||||
| Angel | Aug 10, 2022 | ||||
| Seed | Sep 1, 2021 |
Bivision Biomedical Technology (Nanjing) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IDG Capital | Series B |
| Kaitai Capital | Angel, Seed |
| Lichen Capital | Series A, Angel |
| Wuxi Capital Group Co.,Ltd | Series B |
| Yijing Capital | Seed |
| Guohai Innovation Capital Investment Management | Series B |
| Gaorong Capital | Series B, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
$57M round led by IDG Capital
- Jan 17, 2025
Raised $14M led by CICC NOSG Fund.
Bivision Biomedical Technology (Nanjing) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Bivision Biomedical Technology (Nanjing) Co., Ltd.'s valuation, stock price, and market status.
Is Bivision Biomedical Technology (Nanjing) Co., Ltd. a public or private company?
Bivision Biomedical Technology (Nanjing) Co., Ltd. is a private company.
What is the current stock price of Bivision Biomedical Technology (Nanjing) Co., Ltd.?
Bivision Biomedical Technology (Nanjing) Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Bivision Biomedical Technology (Nanjing) Co., Ltd. worth (valuation)?
Valuation information for Bivision Biomedical Technology (Nanjing) Co., Ltd. is not publicly available.
Can I buy Bivision Biomedical Technology (Nanjing) Co., Ltd. stock?
Bivision Biomedical Technology (Nanjing) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Bivision Biomedical Technology (Nanjing) Co., Ltd.'s last funding round?
Bivision Biomedical Technology (Nanjing) Co., Ltd.'s most recent funding round was Series B on May 19, 2026.
Who are the main investors in Bivision Biomedical Technology (Nanjing) Co., Ltd.?
Key investors in Bivision Biomedical Technology (Nanjing) Co., Ltd. include IDG Capital, Kaitai Capital, Yijing Capital, Gaorong Capital.
Will Bivision Biomedical Technology (Nanjing) Co., Ltd. IPO soon?
No public IPO plans have been announced for Bivision Biomedical Technology (Nanjing) Co., Ltd..
How can I track Bivision Biomedical Technology (Nanjing) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bivision Biomedical Technology (Nanjing) Co., Ltd.'s secondary market activity and sign up for updates.